IONS vs TRIP · rev $226.6M vs P/E 39, rev $1.83B
Ionis Pharmaceuticals Inc (IONS) versus TripAdvisor Inc (TRIP) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
TripAdvisor Inc (TRIP) is a travel services company listed on US.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported TRIP revenue for 2024-12-31 was $1.83B. Net income was $5.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. TRIP currently screens at market cap $2.19B and trailing P/E 39.2.
IONS currently screens at market cap $12.28B. TRIP currently screens at market cap $2.19B and trailing P/E 39.2.
Not investment advice. Open the IONS and TRIP stock pages for the full models.
Not investment advice.